Sustained activation of EGFR-ERK1/2 signaling limits the response to tigecycline-induced mitochondrial respiratory deficiency in liver cancerResearch in context

MLA

Yangyang Zhou, et al. “Sustained Activation of EGFR-ERK1/2 Signaling Limits the Response to Tigecycline-Induced Mitochondrial Respiratory Deficiency in Liver CancerResearch in Context.” EBioMedicine, vol. 87, no. 104397-, Jan. 2023. EBSCOhost, https://doi.org/10.1016/j.ebiom.2022.104397.

APA

Yangyang Zhou, Siying Wang, Wei Wu, Jing Ling, Haoyu Li, Qi Jia, Jiaojiao Zheng, Xingling Zheng, Ruobing Yu, Qiangxin Wu, Yaoping Shi, Cor Lieftink, Roderick L. Beijersbergen, Shengxian Yuan, René Bernards, Haojie Jin, & Wenxin Qin. (2023). Sustained activation of EGFR-ERK1/2 signaling limits the response to tigecycline-induced mitochondrial respiratory deficiency in liver cancerResearch in context. EBioMedicine, 87(104397-). https://doi.org/10.1016/j.ebiom.2022.104397

Chicago

Yangyang Zhou, Siying Wang, Wei Wu, Jing Ling, Haoyu Li, Qi Jia, Jiaojiao Zheng, et al. 2023. “Sustained Activation of EGFR-ERK1/2 Signaling Limits the Response to Tigecycline-Induced Mitochondrial Respiratory Deficiency in Liver CancerResearch in Context.” EBioMedicine 87 (104397-). doi:10.1016/j.ebiom.2022.104397.